These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23237063)

  • 1. Interleukin-10 gene promoter and NFKB1 promoter insertion/deletion polymorphisms in systemic sclerosis.
    Salim PH; Jobim M; Bredemeier M; Chies JA; Brenol JC; Jobim LF; Xavier RM
    Scand J Immunol; 2013 Feb; 77(2):162-8. PubMed ID: 23237063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proximal interleukin-10 gene polymorphisms in Italian patients with systemic sclerosis.
    Beretta L; Cappiello F; Barili M; Scorza R
    Tissue Antigens; 2007 Apr; 69(4):305-12. PubMed ID: 17389013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-1A rs1800587, IL-1B rs1143634 and IL-1R1 rs2234650 polymorphisms in Iranian patients with systemic sclerosis.
    Abtahi S; Farazmand A; Mahmoudi M; Ashraf-Ganjouei A; Javinani A; Nazari B; Kavosi H; Amirzargar AA; Jamshidi AR; Gharibdoost F
    Int J Immunogenet; 2015 Dec; 42(6):423-7. PubMed ID: 26416393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-10 gene promoter polymorphism in patients with schizophrenia in a region of East Turkey.
    Ozbey U; Tug E; Namli M
    World J Biol Psychiatry; 2009; 10(4 Pt 2):461-8. PubMed ID: 19153889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 1alpha single-nucleotide polymorphism associated with systemic sclerosis.
    Hutyrová B; Lukác J; Bosák V; Buc M; du Bois R; Petrek M
    J Rheumatol; 2004 Jan; 31(1):81-4. PubMed ID: 14705223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis.
    Liakouli V; Manetti M; Pacini A; Tolusso B; Fatini C; Toscano A; Cipriani P; Guiducci S; Bazzichi L; Codullo V; Ruocco L; Dell'orso L; Carubbi F; Marrelli A; Abbate R; Bombardieri S; Ferraccioli G; Montecucco C; Valentini G; Matucci-Cerinic M; Ibba-Manneschi L; Giacomelli R
    Ann Rheum Dis; 2009 Apr; 68(4):584-90. PubMed ID: 18445624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interleukin 23 receptor gene does not confer risk to systemic sclerosis and is not associated with systemic sclerosis disease phenotype.
    Rueda B; Broen J; Torres O; Simeon C; Ortego-Centeno N; Schrijvenaars MM; Vonk MC; Fonollosa V; van den Hoogen FH; Coenen MJ; Sanchez-Román J; Aguirre-Zamorano MA; García-Portales R; Pros A; Camps MT; Gonzalez-Gay MA; Martin J; Radstake TR
    Ann Rheum Dis; 2009 Feb; 68(2):253-6. PubMed ID: 18713787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-10 gene promoter polymorphisms and the risk of nasopharyngeal carcinoma.
    Wei YS; Kuang XH; Zhu YH; Liang WB; Yang ZH; Tai SH; Zhao Y; Zhang L
    Tissue Antigens; 2007 Jul; 70(1):12-7. PubMed ID: 17559576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotype-haplotype correlation of IRF5 in systemic sclerosis: role of 2 haplotypes in disease severity.
    Dieude P; Dawidowicz K; Guedj M; Legrain Y; Wipff J; Hachulla E; Diot E; Sibilia J; Mouthon L; Cabane J; Amoura Z; Crakowski JL; Carpentier P; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y
    J Rheumatol; 2010 May; 37(5):987-92. PubMed ID: 20231204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphism of the NFKB1 affects the serum inflammatory levels of IL-6 in Hashimoto thyroiditis in a Turkish population.
    Koc A; Batar B; Celik O; Onaran I; Tasan E; Sultuybek GK
    Immunobiology; 2014 Jul; 219(7):531-6. PubMed ID: 24703107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of -318 C/T and +49 A/G cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms with a clinical subset of Italian patients with systemic sclerosis.
    Balbi G; Ferrera F; Rizzi M; Piccioli P; Morabito A; Cardamone L; Ghio M; Palmisano GL; Carrara P; Pedemonte S; Sessarego M; De Angioletti M; Notaro R; Indiveri F; Pistillo MP
    Clin Exp Immunol; 2007 Jul; 149(1):40-7. PubMed ID: 17459075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-nucleotide polymorphisms in CCL2 gene are not associated with susceptibility to systemic sclerosis.
    Carulli MT; Spagnolo P; Fonseca C; Welsh KI; duBois RM; Black CM; Denton CP
    J Rheumatol; 2008 May; 35(5):839-44. PubMed ID: 18381789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between Thr21Met and Ser89Asn polymorphisms of the urotensin II gene and systemic sclerosis.
    Pehlivan Y; Gogebakan B; Oztuzcu S; Ozgen M; Cetin GY; Bayraktar R; Cengiz B; Kisacik B; Koca SS; Donmez S; Sayarlioglu M; Demiryurek AT; Onat AM
    J Rheumatol; 2012 Jan; 39(1):106-11. PubMed ID: 22045841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nuclear factor-kB functional promoter polymorphism is associated with endometriosis and infertility.
    Bianco B; Lerner TG; Trevisan CM; Cavalcanti V; Christofolini DM; Barbosa CP
    Hum Immunol; 2012 Nov; 73(11):1190-3. PubMed ID: 22902396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allograft inflammatory factor-1 and tumor necrosis factor single nucleotide polymorphisms in systemic sclerosis.
    Otieno FG; Lopez AM; Jimenez SA; Gentiletti J; Artlett CM
    Tissue Antigens; 2007 Jun; 69(6):583-91. PubMed ID: 17498268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin axis polymorphisms in patients with scleroderma.
    Fonseca C; Renzoni E; Sestini P; Pantelidis P; Lagan A; Bunn C; McHugh N; Welsh KI; Du Bois RM; Denton CP; Black C; Abraham D
    Arthritis Rheum; 2006 Sep; 54(9):3034-42. PubMed ID: 16947775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study on the relationship between interleukin-10 promoter polymorphism and autoimmune liver disease].
    Chen QB; Fan LY; Zhong RQ; Tu XQ; Yuan Y; Zhu Y; Ye WM; Lu HQ; Han HX
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):356-8. PubMed ID: 15225432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ability of epistatic interactions of cytokine single-nucleotide polymorphisms to predict susceptibility to disease subsets in systemic sclerosis patients.
    Beretta L; Cappiello F; Moore JH; Barili M; Greene CS; Scorza R
    Arthritis Rheum; 2008 Jul; 59(7):974-83. PubMed ID: 18576303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus.
    Lazarus M; Hajeer AH; Turner D; Sinnott P; Worthington J; Ollier WE; Hutchinson IV
    J Rheumatol; 1997 Dec; 24(12):2314-7. PubMed ID: 9415634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The IL-33 gene is related to increased susceptibility to systemic sclerosis.
    Koca SS; Pehlivan Y; Kara M; Alibaz-Oner F; Oztuzcu S; Yilmaz N; Cetin GY; Kisacik B; Ozgen M; Pamuk ON; Direskeneli H; Sayarlioglu M; Onat AM
    Rheumatol Int; 2016 Apr; 36(4):579-84. PubMed ID: 26743213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.